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musculoskeletal conditions amongst clients of a
primary health care facility in an under-resourced




Background: The extent of disease burden of musculoskeletal conditions (MSC) not due to injury has not been
well determined in sub-Saharan Africa. The 1999 Global Burden of Disease study estimated the prevalence of
osteoarthritis and rheumatoid arthritis to be 150/100,000 compared to 1,500/100,000 in Europe. The objective of
the study was to determine the prevalence of MSC and the functional implications in a sample of people
attending community health centres in Cape Town, South Africa.
Methods: A cross-sectional, descriptive study was conducted in clinics in two resource poor communities. Phase I
consisted of screening and those who screened positive for peripheral or spinal joint pain went on to complete
Phase II, which included the Stanford Health Assessment Questionnaire.
Results: 1005 people were screened in Phase I. Of these, 362 (36%) reported MSC not due to injury in the past
three months. Those with MSC had higher rates of co-morbidities in every category than those without. The mean
Disability Index for those with MSC was mild to moderate and moderate to severe in those over 55 years.
Conclusions: Although the sample may not be representative of the general community, the prevalence is
considerably greater than those reported elsewhere even when the population of the catchment area is used as a
denominator, (367/100 000). The common presentation of MSC with co-morbid diabetes and hypertension requires
holistic management by appropriately trained health care practitioners. Any new determination of burden of
disease due to MSC should recognise that these disorders may be more prevalent in developing countries than
previously estimated.
Background
Musculoskeletal conditions (MSC) are prevalent in
developed countries and are commonly reported to
result in pain, disability and loss of function [1-3]. The
burden of disease (BoD) methodology has been used to
quantify the impact of these conditions and it reports
t h eb u r d e ni nt e r m so fD i s a b i l i t yA d j u s t e dL i f eY e a r s
(DALYs), which reflect both the mortality (years of life
lost, YLLs) and morbidity (years of life lived with dis-
ability, YLDs) associated with a condition. Correct esti-
mates of DALYs require accurate prevalence data and
an estimation of the impact of the disability associated
with a condition, a disability weight. Currently there are
plans to estimate the global burden of disease based on
2005 data (Joshua Solomon, personal communication)
and it is essential that data be available upon which to
base accurate estimates of the burden due to non-fatal
conditions in general and musculoskeletal conditions in
particular. An accurate estimation will assist policy
makers in making well informed decisions related to
resource allocations and subsequent management of
those with MSC.
In the 1990 Global BoD study, MSC were estimated to
account for 4.3% of the DALYs and osteoarthritis (OA)
was the third largest contributor (27.3%) to the YLDs in
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1% to DALYs and OA was not listed amongst the top
ten major contributors to YLDs in the developing world
[4]. This discrepancy relates to the estimated all age pre-
valence rates of 325 for Rheumatoid Arthritis (RA) and
11 6 1 / 1 0 00 0 0f o rO Ai nE u r o p ec o m p a r e dt o3 4a n d
110/100 000 in Sub-Saharan Africa. In the 2000 South
African Burden of disease study[5], MSC were estimated
to contribute relatively little to the burden of all condi-
tions examined and were ranked 20
th o u to f2 4c o n d i -
tions. However, this burden was not calculated from
empirical data but was based on the ratios of YLDs to
YLLs estimated by the World Health Organisation
(WHO) for the Afro E region, of which South Africa is
a part, for each of the disease categories[5]. It is clear
that if the burden estimates mentioned above are
accepted, the resources diverted to the management of
musculoskeletal conditions will be relatively few. It
becomes necessary to therefore examine to what extent
these estimates might be correct.
There appear to be very few studies in developing
countries that present grounds for challenging the above
prevalence estimates. The MSC are commonly over-
looked by researchers due to the apparent greater
urgency of investigating infectious diseases[6]. The
WHO has recognized that: “much research has been
directed at fatal diseases, whereas crippling diseases are
commonly neglected - yet the social and economic bur-
den which the latter impose, is probably greater”[7].
T h e r ei ss t r o n ge v i d e n c et os h o wt h er e l a t i o n s h i p
between disability and MSC with indications that people
living in socially deprived areas are more prone to mus-
culoskeletal symptoms and have poorer resultant func-
tional outcomes[3,8]. A study on the burden of disease
in Zimbabwe indicated that OA was the eleventh high-
est contributor to YLDs[9]. In addition, a community
based survey in a Zimbabwe township indicated that
OA and back pain were the second and third most com-
mon causes of disability with a prevalence rate of 1531/
100 000 for back disorders and OA combined[10], a
rate much closer to the European prevalence rate
reported above than the BoD estimates.
There is a paucity of information relating to the preva-
lence of MSC in South Africa and the functional impact
of these conditions. A few publications have reported on
t h ee p i d e m i o l o g yo fR Ai ns p e c i f i ce t h n i cg r o u p si n
South Africa but do not report on the prevalence of MSC
[2,8,11-13]. Unfortunately it was beyond the scope of this
present study to undertake a community based preva-
lence study. However, as the prevalence of joint and mus-
cle conditions in those who utilise public facilities should
influence the resources that should be made available for
the management of these conditions, it was deemed use-
ful to establish the prevalence of these conditions in
adult attendees of clinics in under-resourced areas. The
aim of this study was to determine the prevalence of
MSC, defined as those presenting with either peripheral
or spinal joint pain, and their functional implications in a
sample of people attending two community health cen-
tres in Cape Town, South Africa.
Methods
Research setting
A cross-sectional, descriptive study was conducted in
clinics serving two resource poor communities each of
approximately 50 000 inhabitants which were histori-
cally disadvantaged in the apartheid era[14]. The popu-
lation served by these clinics are approximately
equivalent in terms of gender and ethnic groups and the
majority of the population are between the ages of 18 -
34 years[14]. The most common languages spoken were
IsiXhosa (45%) and Afrikaans (41%). In the one area
53% of residents live in informal housing/shacks with
one third having no access to electricity and indoor run-
ning water. In the other community, 71% live in formal
housing with both electricity and running water. Unem-
ployment in both suburbs is high (one-third to one-half
unemployed) and less than 10% of the population of
either suburb has completed all 12 years of schooling
[14].
The clinics at which data collection took place were
chosen for the study as they are well established facil-
ities with a good base of multidisciplinary team mem-
bers. The clinics are easily accessible being within
walking distance of all residents. Both clinics are well
attended, serving 600, and 400 people per day
respectively.
Sample
A sample of convenience was obtained with all adults
attending the health care centres on the days when data
collection took place being eligible for inclusion. Inclu-
sion criteria included being over the age of 18, willing
to participate in the study, and attending the clinic for
personal health-related reasons. Subjects too ill to parti-
cipate, or who could not answer the questionnaire in
one of the three languages of English, Afrikaans or isiX-
hosa were excluded. In order to detect a prevalence rate
of 14% (12-16% confidence intervals) it was calculated
that a sample of 791 would be required[15].
Measurement instruments
A screening instrument was developed which included
Phase I and Phase II of the COPCORD questionnaire
and the Stanford Health Assessment Questionnaire -
Disability Index (HAQ).
The COPCORD is a valid and reliable measurement
instrument which has been used in many developing
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modified to include South African language groups
(English, Afrikaans, IsiXhosa, IsiZulu and Other). Sub-
jects, who screened positive for peripheral or spinal
joint pain (PJP/SJP) not due to trauma or injury on
Phase I of the COPCORD, entered the second phase of
the study, completing the Phase II COPCORD and the
HAQ.
A valid, reliable and culturally appropriate version of
the HAQ in South African English and Afrikaans was
used[18]. In the HAQ, the Disability Index (DI) is calcu-
lated based on the categories of dressing, arising, eating,
walking, hygiene, reach, grip, and common activities and
can range from 0 (no disability) to 3 (Unable to perform
in any category).
The questionnaires were translated into isiXhosa and
Afrikaans where translated versions were not available,
using a forward-translation, back-translation methodol-
ogy. Following piloting with 10 subjects, the method of
administration of the questionnaires was changed from
self-administration to administration by research assis-
tants to prevent omission of data.
Procedure
Ethical approval for the study was granted by the Medi-
cal Research Ethics Committee of the University of
Cape Town. Permission to conduct the study was
granted by the clinic authorities. Subjects were
approached while waiting in queues for medical atten-
tion. Each subject completed a written informed consent
prior to Phase I. Subjects reporting PJP/SJP not due to
injury were asked to proceed to Phase II of the study.
Statistical Analysis
This study made use of descriptive statistical analysis to
determine mean values and frequencies of demographic
information gathered. The point prevalence estimate of
people affected by musculoskeletal conditions in the
given sample was calculated. Sub-group analysis of the
DI scores were performed using frequency tables, t-
tests, the one-way ANOVA and Spearman correlations.
Results
Total Sample
There were 1290 people approached to participate in
the study, 266 did not wish to participate and 19 were
not eligible. Thus a total of 1005 people were screened
(the population). Of these, 362 reported PJP/SJP not due
to injury in the past three months (the cases).
Females represented 63% of the population. The aver-
age age of the population was 46 ± 16 years (range 18 -
97); with the 40 to 60 year old age group representing
40% of the population. Almost two thirds (63.1%) were
not married and the majority (73.6%) lived in brick
housing. Almost all were literate (91.8%) with 41%
obtaining school leaving certificates. Previous or current
smoking habits were reported by 52% and 39% of the
population reported current or previous alcohol
consumption.
The majority of the population (64%) were visiting the
day hospital to consult with a nurse or doctor. The
most common health problems experienced by partici-
pants visiting the clinic in the last three months were
hypertension; joint/muscle pain; diabetes; lung; stomach
and heart problems (Table 1). The number of subjects
attending the clinic for musculoskeletal problems only,
which were not due to trauma or injury, was 70 (6.9%).
Comparison of Cases and Controls
Three hundred and sixty two subjects reported PJP/SJP
that was not due to trauma and progressed to Phase II.
This represents a prevalence rate of 36% in the clinic
population. Table 2 compares the gender and housing
conditions of the cases and the controls. Gender was
associated with inclusion in the sample with more
females belonging to this group.
The mean age of the sample was 51.7 ± 15.3 yrs
which was 8.5 years greater than the population mean
(p < 0.001). The most common co-morbidities in the
sample were hypertension (59.1%), diabetes (24.8%) and
heart problems (18.9%). As can be seen in Table 1; with
the exception of infection, the cases reported more pro-
blems than the controls in every category of co-
morbidity.
Back pain was by far the most common complaint,
both in isolation (18.5%) and combined with peripheral
pain (55%). In general, the majority of cases had pain in
more than one joint, although as can be seen in Table
3, isolated back and knee pain were common.
Pain was most commonly reported on awakening.
With regard to stiffness, 80% (203) of the cases experi-
enced stiffness after awakening or long periods of rest
with 85% reporting improvement with movement or
exercise. The stiffness was reported to last for more
than 30 minutes by 51% (103) of this group. There was
no relationship between anatomical region of symptoms
and behaviour of pain or stiffness.
In the cases where a previous diagnosis had been
made (15%), the majority (60%) had been diagnosed
with joint pathology. The most common diagnosis was
arthritis (76%) followed by OA (10%) and RA (5%).
Functional Outcomes
Figure 1 is a representation of the functional results as
recorded with the HAQ. The categories of “Reaching”,
“Walking”, “Rising” and “Activities” caused most diffi-
culty for the greatest number of cases. The majority had
at least “some difficulty” in climbing up 5 stairs; 15.4%
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object. The categories of “Dressing and Grooming”, “Eat-
ing”, “Hygiene” and “Grip” caused the least functional
limitations.
The mean DI for the sample was 0.8 (mild to moder-
ate disability). The mean DI for males and females were
0.66 and 0.85 respectively. No significant difference was
found between the two (p = 0.657, SD = 0.36). Explora-
tion of the DI according to age revealed that mean DI
increased with age with a positive correlation between
age and DI (r = 0.31; p < 0.001).
Discussion
The researchers were constrained in their choice of
research design and undoubtedly a community based
survey would have yielded more useful information.
However the study did uncover some important results.
Over one third of clinic attendees had MSC not due
to trauma or previous injury. This figure is higher than
those reported in community based studies in the USA
(24%), Mexico (17%) and the Philippines (16%)[7,16,19].
I ti sn o t a b l et h a tt h ea v e r a g ea g eo ft h ec l i n i ca t t e n d e e s
was 8.5 years older than the background population and
it may be that an increase in MSC could be expected in
an older population.
Using the figure of 362 people reporting MSC the
community prevalence rate can be estimated. The catch-
ment area of the clinics has a population of approxi-
mately 100 000, the community prevalence rate is
therefore at least 362/100 000 which is over twice the
estimated BoD prevalence rate for sub-Saharan Africa of
144/100 000 for OA and RA combined[4]. It would
appear that the prevalence of MSC affecting muscles
and joints needs to be revisited in the next round of
BoD estimations.
Although other studies have demonstrated that
females are more likely to utilise public health services
[1,20-22], the gender distribution in clinic attendees was
approximately equal with 54% female. This was not so
for subjects in the cases (those with PJP/SJP not due to
injury) and as reported in the literature, the presence of
joint and muscle pain was significantly associated with
gender. More than 80% of the cases were female, a far
larger proportion than a previous study which reported
the ratio of women to men who were suffering from
joint pain to be 1,6:1[7]. This increased prevalence of
Table 1 The most common health problems experienced by all participants (n = 1005), the controls (n = 643) and the
cases, those with MSC (n = 362).
% Problems experienced in the last
three months in the controls
(n = 643)
% Problems experienced in the last three
months in cases (those with MSC)
(n = 362)
% Problems experienced in the last





Hypertension 21.4 59.1 35.1










Depression 3.6 13.0 6.9
Infection 4.1 3.9 3.9
Table 2 Comparison of controls and cases.
Controls (n = 643)
Frequency (%)
Cases (n = 362)
Frequency (%)
Chi Square P value
Gender
Male 298 (46.4) 72 (19.9) 69.7 < .001
Female 345 (53.7) 290 (80.1)
Total 643 362
Housing
Informal 179 (27.8) 85 (23.6) 2.2 0.138
Brick 464 (72.2) 276 (76.5)
Total 643 361









Other joints 28 7.7
Total 362 100
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musculoskeletal conditions including RA, OA and fibro-
myalgia[19,23].
The large number of patients attending the clinic
either solely to have joint or muscle pain treated (7%) or
with pain as a co-morbidity to their other illnesses (33%)
implies that clinic staff need to be prepared to manage
MSC well through accurate diagnosis and appropriate
management. Staff need to be trained to recognise and
refer patients to appropriate services. Such services
range from tertiary care for surgical intervention to pri-
mary care rehabilitation services in the community.
Only 15% of the cases had been previously diagnosed
and the majority of these with generic ‘arthritis’.T h e
majority had co-morbidities related to age and life-style,
including chronic diseases such as hypertension, dia-
betes and heart problems. It would appear that manage-
ment of the chronic diseases of life-style should include
Figure 1 Functional Outcomes on the HAQ of those presenting with PJP/SJP (the sample).
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hensive management package should include medica-
tion, exercise and advice for all related co-morbidities.
In addition, the link between depression (reported by
13% with joint pain) and joint pain needs attention. Pre-
vious studies have linked depression to RA and suggest
this association to stem from the functional limitations
experienced by people living with RA[24].
The back, knees and shoulders were the most com-
monly affected joints overall with slightly fewer males
affected in each of these three groups. These findings
are similar to those in other countries[7,25]. The mean
DI for those with MSC was 0.8, indicating mild to mod-
erate disability. This is a similar result to a previous
study investigating joint disease in an outpatient clinic
in Finland which reported more than half the population
under investigation to have a DI between 0 and 1[26].
This is a somewhat surprising finding as previous
authors have reported on poorer functional outcomes in
people with MSC living in socially deprived areas[8]. A
more comprehensive community based study would
provide further insight.
In this study the 55+ age group had a mean DI indi-
cating moderate to severe disability. It is recognised that
MSC increase in prevalence and severity with age[20].
This is also reflected in the age distribution of the sam-
ple as the 55+age range made up 53% of the sample.
Whole body functions such as “running errands” were
the most difficult for subjects. Subjects with combined
joint involvement had the highest mean DI indicating a
link between the number of joints involved and resul-
tant disability. This suggest that people suffering from
MSC might benefit from treatment programmes which
focus more on rehabilitation and maintenance of gross
motor and whole body functions.
Several limitations were identified in this study. Firstly
the recruitment of subjects at health care centres may
bias the results as this group may represent the less
healthy members of their communities and as such the
results should not be interpreted to reflect the preva-
lence of MSC in the community as a whole. During
data collection, some subjects were lost due to the
length of Phase II of the questionnaire with subjects
being unable to complete interviews prior to leaving the
queue for their appointment.
It is, therefore, recommended that future studies con-
duct door to door community surveys in order to deter-
m i n eam o r ea c c u r a t ep r e v a l e n c eo fr h e u m a t i ca n d
musculoskeletal conditions. In addition the use of Phase
III of the COPCORD study would greatly enhance infor-
mation gained by making definite diagnoses and there-
fore determining an accurate prevalence.
Conclusion
The prevalence of musculoskeletal conditions in this
clinic based study was found to be 36%. Although the
sample may not be representative of the community in
general, the prevalence, even when the population of the
catchment area is used as a denominator, is considerably
greater than those reported in community studies in the
developed and developing countries throughout the
world.
There was an expected correlation between age and
disability. Whole body functions described on the HAQ
such as “running errands” caused considerable difficulty
for subjects. This is also reflected in the finding that
combined joint involvement causes more disability than
isolated joint involvement. However, the extent of the
disability was regarded as mild to moderate in the whole
sample and moderate to severe in the older age group.
These findings might have implications for establishing
appropriate disability weights for QALY or DALY
calculation.
When planning and providing appropriate services in
primary care facilities, it is suggested that assessment of
the community should be the first step taken[27]. The
high prevalence rates of MSC in this sample group and
the subsequent mild to moderate disability ensuing rein-
forces the previously highlighted need for appropriately
trained health care practitioners at primary healthcare
centres[2]. In developing countries such as South Africa
where access to tertiary healthcare is limited, manage-
ment of both the illness and rehabilitation of disability
at these primary health care centres needs to be
addressed.
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